Santhera Pharmaceuticals of Switzerland has raised a gross CHF 15.9 million in a private share placement with Ares Life Sciences, an investment vehicle controlled by the Bertarelli family. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals
